Psa and Klk2 As Therapeutic Targets and Molecules Inhibiting Psa and Klk2
Disclosed herein are compositions and methods relating to prostate-specific antigen (PSA), KLK2 and androgen receptor. Further provided are methods and compositions for inhibiting PSA and/or KLK2 activity. Further provided are compositions and methods for treating or preventing cancer.
CHANG CHAWNSHANG [US]
Type of Offer:
« More Biotech Patents